+91 9313743790 info@syncbioresearch.com

Preclinical & Toxicological.

The mission of SyncBio Research is to support the preclinical and development of biologics, biosimilars, peptides, protein medicines, vaccines, and other innovative biologics therapeutic products.

Screening Studies (invivo / invitro)

  • Anti-Cancer Activity
  • Anti-Diabetic & Anti-Obesity Activity
  • Anti-HIV Activity
  • Anti-Inflammatory & Anti-Arthritic Activity
  • DMPK Study (PK/PD; PK/TK)
  • Other Customized Product Screening Services

Toxicological Studies (invivo / invitro)

  • Dose Range Finding (DRF)
  • Maximum Tolerable Dose (MTD)
  • Acute (All Routes) & Sub-Acute
  • Chronic & Sub-Chronic
  • Skin Sensitization Studies by GPMT
  • Inhalation
  • Skin, Mucous Membrane and Eye Irritation Studies
  • Carcinogenicity studies

Reproductive & Developmental Toxicity Studies

  • Developmental Toxicity
  • Combined Reproductive / Developmental Toxicity
  • One / Two Generation Reproductive Toxicity
  • Prenatal Developmental Toxicity
  • Extended One-Generation Reproductive Toxicity

Genotoxicity Studies

  • Chromosome Aberration Test
  • Bone Marrow Chromosome Aberration Test
  • Micronucleus Assay
  • Bacterial Reverse Mutation Test (Ames test)
  • Comet Assay

Copyright 2023 © SyncBio Research, All Rights Reserved